AAAAAA
Results:
1-17
|
Results: 17
Authors:
Domenech, P
Barry, CE
Cole, ST
Citation: P. Domenech et al., Mycobacterium tuberculosis in the post-genomic age, CURR OPIN M, 4(1), 2001, pp. 28-34
Authors:
Schroeder, BG
Barry, CE
Citation: Bg. Schroeder et Ce. Barry, The specificity of methyl transferases involved in trans mycolic acid biosynthesis in Mycobacterium tuberculosis and Mycobacterium smegmatis, BIOORG CHEM, 29(3), 2001, pp. 164-177
Authors:
Manca, C
Tsenova, L
Bergtold, A
Freeman, S
Tovey, M
Musser, JM
Barry, CE
Freedman, VH
Kaplan, G
Citation: C. Manca et al., Virulence of a Mycobacterium tuberculosis clinical isolate in mice is determined by failure to induce Th1 type immunity and is associated with induction of IFN-alpha/beta, P NAS US, 98(10), 2001, pp. 5752-5757
Authors:
Slayden, RA
Barry, CE
Citation: Ra. Slayden et Ce. Barry, The genetics and biochemistry of isoniazid resistance in Mycobacterium tuberculosis, MICROBES IN, 2(6), 2000, pp. 659-669
Authors:
Barry, CE
Wilson, M
Lee, R
Schoolnik, GK
Citation: Ce. Barry et al., DNA microarrays and combinatorial chemical libraries: tools for the drug discovery pipeline, INT J TUBE, 4(12), 2000, pp. S189-S193
Authors:
Slayden, RA
Lee, RE
Barry, CE
Citation: Ra. Slayden et al., Isoniazid affects multiple components of the type II fatty acid synthase system of Mycobacterium tuberculosis, MOL MICROB, 38(3), 2000, pp. 514-525
Authors:
Stover, CK
Warrener, P
VanDevanter, DR
Sherman, DR
Arain, TM
Langhorne, MH
Anderson, SW
Towell, JA
Yuan, Y
McMurray, DN
Kreiswirth, BN
Barry, CE
Baker, WR
Citation: Ck. Stover et al., A small-molecule nitroimidazopyran drug candidate for the treatment of tuberculosis, NATURE, 405(6789), 2000, pp. 962-966
Authors:
De Voss, JJ
Rutter, K
Schroeder, BG
Su, H
Zhu, YQ
Barry, CE
Citation: Jj. De Voss et al., The salicylate-derived mycobactin siderophores of Mycobacterium tuberculosis are essential for growth in macrophages, P NAS US, 97(3), 2000, pp. 1252-1257
Authors:
DeBarber, AE
Mdluli, K
Bosman, M
Bekker, LG
Barry, CE
Citation: Ae. Debarber et al., Ethionamide activation and sensitivity in multidrug-resistant Mycobacterium tuberculosis, P NAS US, 97(17), 2000, pp. 9677-9682
Authors:
Wang, L
Slayden, RA
Barry, CE
Liu, J
Citation: L. Wang et al., Cell wall structure of a mutant of Mycobacterium smegmatis defective in the biosynthesis of mycolic acids, J BIOL CHEM, 275(10), 2000, pp. 7224-7229
Authors:
Primm, TP
Andersen, SJ
Mizrahi, V
Avarbock, D
Rubin, H
Barry, CE
Citation: Tp. Primm et al., The stringent response of Mycobacterium tuberculosis is required for long-term survival, J BACT, 182(17), 2000, pp. 4889-4898
Authors:
Behr, MA
Schroeder, BG
Brinkman, JN
Slayden, RA
Barry, CE
Citation: Ma. Behr et al., A point mutation in the mma3 gene is responsible for impaired methoxymycolic acid production in Mycobacterium bovis BCG strains obtained after 1927, J BACT, 182(12), 2000, pp. 3394-3399
Authors:
Barry, CE
Slayden, RA
Sampson, AE
Lee, RE
Citation: Ce. Barry et al., Use of genomics and combinatorial chemistry in the development of new antimycobacterial drugs, BIOCH PHARM, 59(3), 2000, pp. 221-231
Authors:
Barry, CE
Citation: Ce. Barry, The development of new chemotherapeutics for multidrug-resistant tuberculosis, RESURG EMER, 1, 2000, pp. 241-252
Authors:
Manca, C
Tsenova, L
Barry, CE
Bergtold, A
Freeman, S
Haslett, PAJ
Musser, JM
Freedman, VH
Kaplan, G
Citation: C. Manca et al., Mycobacterium tuberculosis CDC1551 induces a more vigorous host response in vivo and in vitro, but is not more virulent than other clinical isolates, J IMMUNOL, 162(11), 1999, pp. 6740-6746
Authors:
De Voss, JJ
Rutter, K
Schroeder, BG
Barry, CE
Citation: Jj. De Voss et al., Iron acquisition and metabolism by mycobacteria, J BACT, 181(15), 1999, pp. 4443-4451
Authors:
Manca, C
Paul, S
Barry, CE
Freedman, VH
Kaplan, G
Citation: C. Manca et al., Mycobacterium tuberculosis catalase and peroxidase activities and resistance to oxidative killing in human monocytes in vitro, INFEC IMMUN, 67(1), 1999, pp. 74-79
Risultati:
1-17
|